<DOC>
	<DOCNO>NCT00236236</DOCNO>
	<brief_summary>The Registry evaluate HRV Monitor diagnostics change cardiac resynchronization therapy patient heart failure .</brief_summary>
	<brief_title>The HF-HRV Registry</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients receive first CRTD Patients sign date Patient Informed Consent prior device implant Patients available willing attend followup visit study center enrol Patients anticipated receive pacing mode DDD VDD ( i.e. , chronic atrial fibrillation patient exclude ) , patient anticipate receive adaptive rate therapy Patients young 18 year age Patients whose life expectancy less sixmonths due medical condition Patients likely receive tricuspid valve prosthesis Patients currently enrol another investigational study would directly impact treatment outcome current study Women pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
</DOC>